| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00467-006-0211-6 |
| P698 | PubMed publication ID | 17186590 |
| P2093 | author name string | James C M Chan | |
| Mohamed Alaa Thabet | |||
| P2860 | cites work | Vitamin E supplementation and macular degeneration: randomised controlled trial | Q24531484 |
| Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease | Q24550510 | ||
| Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients | Q27863446 | ||
| Vitamin E: function and metabolism | Q28138332 | ||
| Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 | ||
| Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project | Q28176142 | ||
| Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial | Q28182767 | ||
| The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences | Q28188518 | ||
| Vitamin E in humans: demand and delivery | Q28292171 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney | Q28377262 | ||
| Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route | Q28645886 | ||
| Impaired endothelium-dependent vasodilatation in renal failure in humans | Q31832569 | ||
| Hereditary vitamin-E deficiency | Q32061535 | ||
| Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers | Q32135883 | ||
| Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia | Q33645105 | ||
| Vitamin E in diabetes. Increased oxidative stress and its prevention as a strategy to prevent vascular complications? | Q33675741 | ||
| Cardiovascular mortality in children and young adults with end-stage kidney disease | Q74620905 | ||
| Oxidative stress in abetalipoproteinemia patients receiving long-term vitamin E and vitamin A supplementation | Q75354000 | ||
| Cardiovascular morbidity and risk factors in renal transplant patients | Q77292190 | ||
| Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study | Q77647490 | ||
| Role of oxidative stress in diabetic complications: a new perspective on an old paradigm | Q77804864 | ||
| Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients | Q78019572 | ||
| High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes | Q78239341 | ||
| Vitamins A, E and C as non-enzymatic antioxidants and their relation to lipid peroxidation in children with chronic renal failure | Q82065265 | ||
| Efficacious vitamin E treatment in a child with ataxia with isolated vitamin E deficiency | Q82617979 | ||
| Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis | Q93650954 | ||
| Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. | Q33788676 | ||
| Vitamin E treatment of focal segmental glomerulosclerosis: results of an open-label study. | Q33875413 | ||
| Vitamin E and its function in membranes | Q33900377 | ||
| MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q33960122 | ||
| Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials | Q34206974 | ||
| Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease | Q34336191 | ||
| Vitamin E consumption and the risk of coronary heart disease in men. | Q34363912 | ||
| Ataxia with isolated vitamin E deficiency: case report and review of the literature | Q34377959 | ||
| Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. | Q34383377 | ||
| Oxidative stress and diabetic vascular complications | Q34391178 | ||
| Vitamins and minerals: efficacy and safety | Q34434756 | ||
| Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency | Q34490885 | ||
| The European perspective on vitamin E: current knowledge and future research | Q34905197 | ||
| Long-term management of abetalipoproteinaemia. Possible role for vitamin E | Q34989797 | ||
| Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy | Q35074064 | ||
| Oxidant stress in hemodialysis patients: what are the determining factors? | Q35093664 | ||
| Antioxidant nutrients protect against cyclosporine A nephrotoxicity | Q35160383 | ||
| gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells | Q35307368 | ||
| Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial | Q35536924 | ||
| Oxidative stress-induced ischemic heart disease: protection by antioxidants | Q35668141 | ||
| The relationship between antioxidant supplements and oxidative stress in renal transplant recipients: a review | Q35924553 | ||
| Anti-inflammatory effects of alpha-tocopherol | Q36064405 | ||
| Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol | Q36130067 | ||
| Vitamin E, oxidative stress, and inflammation | Q36191081 | ||
| Alpha-tocopherol: roles in prevention and therapy of human disease | Q36218888 | ||
| Failure of vitamin E in clinical trials: is gamma-tocopherol the answer? | Q36270921 | ||
| Reactive oxygen molecules, oxidant injury and renal disease | Q36455874 | ||
| Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus | Q37054999 | ||
| The role of free radicals in the progression of renal disease | Q37711634 | ||
| Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis | Q37749949 | ||
| Role of reactive oxygen metabolites in experimental glomerular disease | Q38682345 | ||
| Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial | Q40568972 | ||
| Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity | Q41886821 | ||
| Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria | Q42200826 | ||
| Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy. | Q42279739 | ||
| Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. | Q42435997 | ||
| Vitamin E‐‐Bonded Cellulose Membrane, Lipoperoxidation, and Anemia in Hemodialysis Patients | Q42441329 | ||
| Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients | Q42505009 | ||
| Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. | Q42528234 | ||
| Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters | Q43586162 | ||
| Vitamin C improves endothelial dysfunction in renal allograft recipients | Q43629078 | ||
| A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. | Q43654533 | ||
| Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients | Q43664509 | ||
| Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. | Q43717110 | ||
| Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. | Q43770080 | ||
| Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. | Q43850038 | ||
| alpha-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients | Q43903142 | ||
| Effects of antioxidants on kidney disease | Q44014859 | ||
| Vitamin E as an antioxidant agent in CAPD patients. | Q44034778 | ||
| Effect of oral vitamin E supplementation in children with cholestasis. | Q44292240 | ||
| Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells | Q44390532 | ||
| 5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients | Q44402747 | ||
| Comparative crossover controlled study using polysulphone and vitamin E coated dialyzers | Q44409539 | ||
| Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats | Q44521372 | ||
| Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease | Q44545033 | ||
| Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study | Q44613226 | ||
| Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. | Q44631288 | ||
| Vitamin E treatment in pediatric obesity-related liver disease: a randomized study | Q44694111 | ||
| Comparison of acute and chronic antioxidant interventions in experimental renovascular disease | Q44726962 | ||
| Accumulation of vitamin E metabolites in the blood of renal failure patients | Q44805383 | ||
| Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study | Q44845974 | ||
| Influence of alpha-tocopherol over the time course of experimental IgA nephropathy | Q44860272 | ||
| A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX). | Q44887832 | ||
| Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study | Q44895355 | ||
| Endothelial dysfunction and oxidative stress in chronic renal failure. | Q45062452 | ||
| Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients | Q45129251 | ||
| Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress | Q45165519 | ||
| Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial | Q46442488 | ||
| Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients. | Q46584942 | ||
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. | Q46722315 | ||
| Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy | Q46748360 | ||
| Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients | Q46749958 | ||
| The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine | Q46867931 | ||
| Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans | Q47729576 | ||
| Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein | Q47739528 | ||
| Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter | Q48418701 | ||
| A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study | Q48725577 | ||
| Vitamin E consumption and the risk of coronary disease in women | Q50126258 | ||
| Cardiovascular disease in pediatric chronic dialysis patients. | Q50698127 | ||
| Development of oxidative stress in chronic kidney insufficiency following the progression of disease. | Q53792120 | ||
| Vitamin E protects renal antioxidant enzymes and attenuates glomerulosclerosis in Adriamycin-treated rats. | Q53961355 | ||
| Supplementation with tomato juice increases plasma lycopene but does not alter susceptibility to oxidation of low-density lipoproteins from renal transplant recipients. | Q54082815 | ||
| Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE Study | Q58040915 | ||
| Long-Term Survival of Children with End-Stage Renal Disease | Q59167828 | ||
| Effects of dietary supplementation with vitamin E on human neutrophil chemotaxis and generation of LTB4 | Q68271554 | ||
| Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-alpha-tocopheryl polyethylene glycol-1000 succinate | Q69398061 | ||
| Reduction of osmotic haemolysis and anaemia by high dose vitamin E supplementation in regular haemodialysis patients | Q70095791 | ||
| Alpha-tocopherol, a potent modulator of endothelial cell function | Q70401588 | ||
| A multivitamin infusion prevents lipid peroxidation and improves transplantation performance | Q70673112 | ||
| Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 | ||
| Formation of alpha-tocopherol complexes with fatty acids. A hypothetical mechanism of stabilization of biomembranes by vitamin E | Q71385811 | ||
| Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein | Q71581079 | ||
| Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy | Q71719762 | ||
| alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism | Q71785121 | ||
| Oxidative stress-induced apoptosis prevented by Trolox | Q72150904 | ||
| Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: studies using deuterated compounds | Q72158342 | ||
| Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion | Q72198281 | ||
| Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E | Q72242513 | ||
| Fc alpha R expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy | Q72473931 | ||
| Left ventricular mass and systolic performance in pediatric patients with chronic renal failure | Q73013974 | ||
| F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes | Q73108194 | ||
| Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients | Q73129026 | ||
| Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen | Q73146514 | ||
| Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
| Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane | Q73235849 | ||
| Oxidative damage in renal transplant patients | Q73304118 | ||
| Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction | Q73323302 | ||
| Does vitamin E bound on dialysis membrane improve the LDL susceptibility to oxidation? Lessons from an in vitro model | Q73342096 | ||
| Vitamin E supplementation and cardiovascular events in high-risk patients | Q73365511 | ||
| Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidney | Q73386899 | ||
| Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis | Q73400195 | ||
| Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E | Q73403573 | ||
| Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients | Q73468638 | ||
| Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis | Q73513154 | ||
| Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer | Q73514241 | ||
| Vitamin E inhibits renal mRNA expression of COX II, HO I, TGFbeta, and osteopontin in the rat model of cyclosporine nephrotoxicity | Q73523857 | ||
| Antioxidant supplementation and chronic renal transplant dysfunction | Q73544637 | ||
| Physiology and biochemistry of endothelial function in children with chronic renal failure | Q73604837 | ||
| Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy | Q73712824 | ||
| Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes | Q73857595 | ||
| Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation | Q73932786 | ||
| Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study | Q74012803 | ||
| Cyclosporine A nephrotoxicity: role of thromboxane and reactive oxygen species | Q74128004 | ||
| Oxidative stress and cardiovascular disease in dialyzed patients | Q74138790 | ||
| Effect of combined supplementation with vitamin E and alpha-lipoic acid on myocardial performance during in vivo ischaemia-reperfusion | Q74198570 | ||
| Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation | Q74532439 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1790-1801 | |
| P577 | publication date | 2006-09-21 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Vitamin E in renal therapeutic regiments | |
| P478 | volume | 21 |
| Q82792668 | Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms |
| Q34106783 | Effects of vitamin E supplementation on renal non-enzymatic antioxidants in young rats submitted to exhaustive exercise stress |
| Q39894679 | Evaluation of certain constituents of antioxidant defense in youth treated in the past for steroid-sensitive idiopathic nephrotic syndrome. |
| Q37244943 | Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders |
Search more.